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IMPORTANCE β-amyloid (Aβ) deposition is one of the hallmarks of Alzheimer disease. Aβ
deposition accelerates gray matter atrophy at early stages of the disease even before
objective cognitive impairment is manifested. Identification of at-risk individuals at the
presymptomatic stage has become amajor research interest because it will allow early
therapeutic interventions before irreversible synaptic and neuronal loss occur. We aimed to
further characterize the cross-sectional and longitudinal relationship between Aβ deposition,
gray matter atrophy, and cognitive impairment.
OBJECTIVE To investigate the topographical relationship of Aβ deposition, gray matter
atrophy, andmemory impairment in asymptomatic individuals with Alzheimer disease
pathology as assessed by Pittsburgh compound B positron emission tomography (PiB-PET).
DESIGN Regional analysis was performed on the cortical surface to relate cortical thickness to
PiB retention and episodic memory.
SETTING The Australian Imaging, Biomarkers, and Lifestyle Study of Aging, Austin Hospital,
Melbourne, Australia.
PARTICIPANTS Ninety-three healthy elderly control subjects (NCs) and 40 patients with
Alzheimer disease from the Australian Imaging, Biomarkers, and Lifestyle Study of Aging
cohort.
INTERVENTION Participants underwent neuropsychological evaluation as well as magnetic
resonance imaging and PiB-PET scans. Fifty-four NCs underwent repeated scans and
neuropsychological evaluation 18 and 36months later.
MAIN OUTCOMES ANDMEASURES Correlations between cortical thickness, PiB retention, and
episodic memory.
RESULTS There was a significant reduction in cortical thickness in the precuneus and
hippocampus associated with episodic memory impairment in the NC PiB-positive (NC+)
group when compared with the NC− group. Cortical thickness was also correlated negatively
with neocortical PiB in the NC+ group. Longitudinal analysis showed a faster rate of gray
matter (GM) atrophy in the temporal lobe and the hippocampi of the NC+ group. Over time,
GM atrophy becamemore extensive in the NC+ group, especially in the temporal lobe.
CONCLUSIONS AND RELEVANCE In asymptomatic individuals, Aβ deposition is associated with
GM atrophy andmemory impairment. The earliest signs of GM atrophy were detected in the
hippocampus and the posterior cingulate and precuneus regions, and with disease
progression, atrophy becamemore extensive in the temporal lobes. These findings support
the notion that Aβ deposition is not a benign process and that interventions with anti-Aβ
therapy at these early stages have a higher chance to be effective.
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A lzheimerdisease (AD) is themost common formofde-mentia, and its prevalence is doubling nearly every 20years, increasing the economic and social burden as-
sociated with the disease.1 Although novel therapeutic strat-
egies are currentlyunder evaluation,presently there isnocure
for AD.2
Grey matter (GM) atrophy is observed in almost all pa-
tientsdiagnosedwithAD. Identifyingpatients at anearly stage
of the disease would enable a better understanding of the
pathophysiological processes at play as well as facilitate the
development and testing of newdrugs thatmay stop or delay
disease onset before irreversible injury occurs. The identifi-
cation of individuals at the presymptomatic stage has there-
fore becomeamajor research interest.3,4 Subjects classified as
havingmild cognitive impairment, often considered as a pro-
dromal stage to AD,5 exhibit the same pattern of GM atrophy
aspatientswithAD.6,7 Several studieshave investigatedpopu-
lation stratification at evenearlier stages of thedisease; for in-
stance, support vector machines were used to identify AD-
like GM atrophy patterns in a healthy elder patient group.8
β-amyloid (Aβ) deposition in the form of extracellular
plaques is one of the pathological hallmarks of AD.Aβburden
has been shown to be associated with GM atrophy,9 and sev-
eral studies have reported the relationship between neocor-
tical Pittsburgh compound B positron emission tomography
(PiB-PET) and global and hippocampus atrophy.10 Aβ deposi-
tion is a slow process that precedes the manifestation of the
AD phenotype for more than 10 years.11-14 It has been re-
ported that early Aβ deposition is found in the posterior cin-
gulate/precuneus (PPC) and orbitofrontal regions.15,16 About
30% of cognitively unimpaired elderly subjects with no sig-
nificant GM atrophy also present with significant PiB
retention,10,17-19 although at levels not as high as observed in
AD.13 This has been proposed by some as preclinical AD.3,20
Other studies9,21 have focused on cognitively unimpaired
individuals with an AD-like cerebrospinal fluid (CSF) profile
or subjects with subjective memory complaints, where a sig-
nificant association between GM atrophy and global and lo-
cal Aβdepositionwas found.9Most reports useGMvolumeas
ameans toquantifyGMatrophy.9,10However, this couldmask
local effects and dilute statistical power, precluding any con-
clusion. Theuse of cortical thickness22-25 provides a local spe-
cific measure of GM changes and hence allows a better re-
gional discrimination of atrophy.
Healthyelderlycontrols (NCs)withhighPiB retentionhave
become the focus of several studies.10,17,26-29 Pittsburgh com-
pound B retention was associated with cortical thickness re-
ductions in the parietal and posterior cingulate regions ex-
tending into the precuneus in a pattern similar to AD.27
However, no significant difference in cortical thickness was
found between NCs with low and high PiB retention. Longi-
tudinal analysis of thecortical volumesofNCs showed that the
annual rate of GM atrophy is faster in subjects with high PiB
retention when comparedwith those with low PiB retention,
a rate that was significantly correlated with baseline neocor-
tical PiB level, most prominently in the lateral temporal and
posterior cingulate cortices.28 Also, episodicmemory impair-
ment, the primary cognitive deficit observed in early AD,was
found to be related to Aβ burden in individuals without
dementia,17,30 especially in the temporal cortex.28
In a similar population as in our previous report28 using
voxel-based morphometry, we used cortical thickness in a
cross-sectional fashion followedbya longer longitudinal analy-
sis to assess if Aβ depositionwas associatedwith GM atrophy
andmemory.
Methods
Participants
Onehundred thirty-threesubjects (93NCsand40patientswith
AD) were included in the study. All participants were part of
the Australian Imaging, Biomarkers, and Lifestyle Study of
Aging31 undergoing both magnetic resonance imaging (MRI)
andPiB-PET scans at theAustinHospital (Melbourne, Austra-
lia).Approval for thestudywasobtainedfromtheAustinHealth
HumanResearchEthicsCommitteeandStVincent’sHealthRe-
searchEthicsCommittee,andwritten informedconsent forpar-
ticipationwasobtained foreachsubjectprior to thescans.Data
fromsomeof theHCshaveappeared inaprevious reportusing
voxel-based morphometry.28
The full methods for the cohort recruitment and evalua-
tion are detailed elsewhere.31 Briefly, all subjects underwent
clinical and neuropsychological examination, and allocation
of individuals to a diagnostic group and exclusion of ineli-
gible individuals were performed by a clinical review panel
based on the screening interview and neuropsychological as-
sessment and according to internationally agreed-on criteria:
patients with AD met standard National Institute of Neuro-
logical and Communicative Disorders and Stroke–
Alzheimer's Disease and Related Disorders Association clini-
cal criteria for possible or probable AD. All NCs performed
within less than 1.5 SDs of the published norms for their age
grouponneuropsychological tests.Theneuropsychological ex-
amination included the Mini-Mental State Examination,
Wechsler Test of Adult Reading, the California Verbal Learn-
ingTest, secondedition,ReyComplexFigureTest, 30-itemBos-
ton Naming Test, Logical Memory II test, Digit Span subtest
of theWechsler Adult Intelligence Scale, third edition, verbal
category fluency (animals and boy’s names), and Stroop test
(Victorian version). A composite episodic memory score was
calculated by averaging the Logical Memory II and California
Verbal Learning Test, second edition long delay recall scores.
MRI and PET Acquisition
All subjects underwent an MRI and a PiB-PET scan. T1-
weightedMRIwasobtainedusing theAlzheimer'sDiseaseNeu-
roimaging Initiative magnetization-prepared rapid gradient
echo protocol at 3 T, with in-plane resolution of 1 × 1mm and
1.2 mm slice thickness.
The PiB-PET scans were acquired using an Allegro PET
camera (Philips). Each participantwas injectedwith 370MBq
of carbon 11–labeled PiB, and a 30-minute acquisition in 3-di-
mensionalmodewas performed starting 40minutes after in-
jection (6 × 5-minute frames). A transmission scan was per-
formed for attenuation correction. The PET images were
Research Original Investigation Aβ Deposition, Cortical Thickness, andMemory
904 JAMANeurology July 2013 Volume 70, Number 7 jamaneurology.com
Downloaded From: https://archneur.jamanetwork.com/ by Rory  Jackson on 10/12/2015
reconstructedusinga3-dimensional rowactionmaximumlike-
lihood algorithm.
Image Analysis
Image Segmentation
The 3-dimensional T1-weighted images for all subjects were
segmented into GM, white matter (WM), and CSF using an
implementation of the expectation maximization segmenta-
tionalgorithm.22Furthermore, topological constraintswereap-
plied to force the GM to be a continuous layer covering the
WM.32 Gray matter segmentation was also topologically cor-
rected in deep sulci.32
To ensure robust and accurate segmentation results, the
segmentation schemeused9different atlases to reduce theer-
ror due to misregistration of the atlas on the MRI.10 Each in-
dividualMRIwas thensegmented9 timesandavoting scheme
provided consensus for pure tissue segmentation.
Partial-Volume Effect and Cortical Thickness Estimation
Partial-volumeeffect inMRIisbecauseofthelimitedspatialreso-
lutionofMRI comparedwith the sizeof anatomical structures.
Accurate classification ofmixed voxels and correct estimation
of theproportionofeachpure tissuehelped to increase thepre-
cisionofcortical thicknessestimation(CTE) inregionswherethis
measurewasparticularlydifficult, suchasdeepsulci.Basedon
thesepuretissuesegmentations,afurthermaximumaposteriori
classificationof voxels intopure tissuesWM,GM, andCSFand
mixed tissuesWM/GMandGM/CSF along the previously com-
puted GM interface was performed, which resulted in a GM
partial-volumeeffectmap.Theclassificationalgorithmalso in-
tegrated a mechanism for detecting sulci with topology-
preservingoperators.32The topological correctionsignificantly
improved the GMclassification.
Once pure tissue segmentation and partial tissue classifi-
cationwere performed, theCTEof the resultingGMwas com-
putedusing a combinedvoxel-based approach.25 TheGMpar-
tial-volume effect map was used to initialize a combined
Lagrangian-Eulerian approach. TheGMpartial-volumeeffect
initialization preserved the efficiency of the Eulerian ap-
proach while improving the accuracy.22
PiB Normalization
The PET images were coregistered with each individual’s MRI
usingSPM5(WellcomeTrustCentre forNeuroimaging).Thecer-
ebellum region of interest (ROI) was then manually drawn on
the individualMRI and transferred to the coregisteredPET im-
agesaspreviouslydescribed.33Scanswerenormalizedusingthe
standardized uptake value ratio (SUVR) method,34 with each
voxel divided by themeanvalue in the cerebellar cortexmask.
The NC group exhibited a bimodal neocortical PiB SUVR
distribution. As previously described, a neocortical SUVR
threshold of 1.4was used to separateNCswith high (NC+) and
low (NC−) PiB retention.10 All subjects with AD in this study
had a neocortical PiB retention higher than 1.4.
Surface-Based Approach
The Internet Brain Segmentation Repository labeling was
propagated from the atlas to the individual subject space to
separate the left and right hemispheres on all segmented
maps. For each subject, left and right hemisphere meshes
were generated from the WM/GM interface.35 Meshes were
topologically corrected in genus 0 surfaces using the Taglut
tool.15,35 Individual meshes were then registered to a com-
monmesh atlas with a Multi-scale EM-ICP algorithm.36 Indi-
vidual meshes were first geometrically smoothed and
EM-ICP registered to a smooth version of the atlas. Then
local curvature features at different smoothing levels were
iteratively introduced into the registration algorithm to bet-
ter match the small and local geometric structures of the
individual mesh to the atlas. The individual thickness val-
ues were then mapped from the image onto the mesh sur-
face and then to the template surface. Hence, each vertex of
the template was associated with a CTE vector correspond-
ing to the CTE value of all individuals at the same spatial
location. The full pipeline is detailed in eFigure 1 (Supple-
ment). The processing pipeline is available as a plug-in of
the open-source software MILXView.1
Robust Statistical Framework
A robust statistical framework was used to ensure against
missegmentation and/or misregistration along the pipeline.
In each group and at each vertex, the 2 first moments of the
CTE distribution were calculated. Each CTE value outside
the 95% likelihood of the vertex groupwise distribution
might result in a missegmentation or misregistration
of the associated subjects at these locations. These CTE
values were replaced by the local mean values of the
associated subjects. A 10-mm Laplace-Beltrami smoothing
was then applied to the CTE values on the template
mesh.
Statistical Analyses
Cortical thickness estimation, neocortical PiB SUVR, and
memory test scores were adjusted for the effects of age. Sig-
nificance was set at P = .05. P values resulting from all statis-
tics were corrected for multiple comparisons using false dis-
covery rates.37 Data are presented as mean (SD) unless
otherwise stated.
Surface ROI Statistical Analysis
First, a vertex-wise t test was performed between the NC−
and AD+ groups. The P value map was thresholded at 5.10−4
and false discovery rate corrected. Vertices with significant
P value– defined regions associated with a high degree of
atrophy in AD (Figure 1). We postulated that early GM atro-
phy may appear in these regions. We particularly focused on
3 regions: the hippocampi, temporal lobes, and a region
encompassing part of the precuneus and the posterior cin-
gulate gyrus (PPC). These 3 anatomical regions were inter-
sected with the T map between the NC− and AD+ groups to
define the anatomical ROIs in which we compared the NC+
and NC− groups.
Surface ROI t Test on the CTE Between NC− and NC+
Second, to assess whether cortical thickness was different
in the NC group with either low or high PiB retention, we
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computed the mean CTE value for all patients in each
ROI and a t test between the NC− and NC+ groups was
performed.
Surface ROI Correlation Between CTE, PiB Retention,
andMemory Test Score in NC−/+
Third, to establish if a highPiB retentiononly affectsNCs, cor-
relationswereassessedbetweencortical thickness ineachROI
and the neocortical PiB retention score in the NC−, NC+, and
AD+ groups. Cortical thickness is believed to be related to
memory performance. Incipient GM atrophy may be associ-
atedwithmemorydecline.Regionof interest correlationswere
thenperformedbetweenCTEandepisodicmemory in thedif-
ferent groups.
Todeterminewhether episodicmemory is correlatedwith
cortical thickness or to Aβ deposition, we performed amulti-
stage regression analysis.38 We computed the partial correla-
tion between cortical thickness and episodic memory while
controlling for PiB SUVR and the partial correlation between
PiB SUVR and episodic memory while controlling for cortical
thickness. All partial correlations were computed with corti-
cal thickness estimated in the PPC, temporal lobe, andhippo-
campus.
Vertex-wise Longitudinal Analysis of the Cortical
Thickness Loss
To assess whether GM atrophy progressed differently in the
NC+andNC−groups,weperformed longitudinal analysisof the
cortical thickness.We computed the vertex-wise atrophy rate
of cortical thickness in both NC groups at 18 and 36 months.
The comparison between the 2 points showed the progres-
sionof thesepatterns. Rates ofGMatrophywere computedby
subtracting the cortical thickness at the first or second point
from the cortical thickness evaluated at baseline and divid-
ingby the timebetweenscans.Linear regressionof the3points
was used to estimate the global rate of atrophy over the 36
months.
Results
Table 1 and Table 2 present the demographic data of the co-
hort examined in the study. There were no significant differ-
ences in sex or years of education between the groups, al-
though the NC+ group was significantly older than the NC−
Figure 1. Cortical Thickness Between the Healthy Control Pittsburgh
Compound B–Negative and Alzheimer Disease Groups
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P value is less than .0005 (false discovery rate corrected). P value maps are of a
vertex-wise t test. Gray matter atrophy is significantly more prominent and
widespread in the Alzheimer disease group than in the healthy control
Pittsburgh compound B–negative group. INF indicates inferior; LAT, lateral;
LT, left; MED, medial; RT, right; and SUP, superior.
Table 1. Demographics for the Cross-sectional Analysis
Group
Mean (SD)
NC− NC+ AD
Sample size 64 29 40
Male/female, No. 29/35 14/15 17/23
Age, y 72.0 (7.3) 78.2 (5.9)a 72.5 (10.9)
Education, y 12.9 (2.6) 12.6 (2.6) 12.0 (2.3)
MMSE score 29.0 (1.2) 28.7 (1.3) 22.4 (5.2)a
Neocortical SUVR 1.3 (0.1) 2.1 (0.4)a 2.5 (0.4)a
Episodic memory score 1.2 (1.9)
(n = 57)
1.3 (1.8)
(n = 33)
−4.7 (1.3)a
(n = 30)
Abbreviations: AD, Alzheimer
disease; MMSE, Mini-Mental State
Examination; NC−, healthy control
Pittsburgh compound B–negative;
NC+, healthy control Pittsburgh
compound B–positive; SUVR,
standardized uptake value ratio.
a Significant difference from the NC−
group (P < .05).
Table 2. Demographics for the Longitudinal Analysis
Group
Mean (SD)
NC− NC+ AD
Sample size 38 15 4
Male/female, No. 18/20 9/6 17/23
Age at baseline, y 71.7 (7.6) 74 (5.9)a 72.5 (10.9)
Education, y 13.4 (2.3) 13.1 (2.5) 12.0 (2.3)
MMSE score at baseline 29.0 (1.2) 29.2 (1.2) 22.4 (5.2)
Neocortical SUVR 1.3 (0.1) 2.2 (0.4)a 2.6 (0.4)a
Abbreviations: AD, Alzheimer
disease; MMSE, Mini-Mental State
Examination; NC−, healthy control
Pittsburgh compound B–negative;
NC+, healthy control Pittsburgh
compound B–positive; SUVR,
standardized uptake value ratio.
a Significant difference from the NC−
group (P < .05).
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group. Pittsburgh compoundB retentionwas significantlydif-
ferent between the NC and AD groups. As expected, Mini-
Mental State Examination scoreswere lower in the AD group.
Therewere no significant differences in episodicmemory be-
tween the NC+ and NC− groups, but the NC+ group presented
with slightly higher scores.
Cross-sectional Analysis
Significant differences between the NC− and AD groups
(P < .0005 corrected)were found inmost regions: the tempo-
ral, occipital, and parietal lobes, as well as the hippocampus,
parahippocampus, and amygdala (Figure 1). Significant dif-
ferences (P < .05 corrected) in CTE between the NC− and NC+
groupswere found in thePPCandhippocampus inbothhemi-
spheres (Figure 2). The P values were slightly smaller in the
right hemisphere.
Themean cortical thickness in thehippocampus andPPC
wassignificantlymoreatrophic in theNC+andAD+groupscom-
pared with the NC− group (eFigure 2). The AD group had
significantly greater GMatrophy than bothNC groups in both
regions.
CorrelationsbetweenCTEandneocortical SUVRin theNC+
group were significant in the PPC bilaterally and in the tem-
poral lobeandhippocampus in the righthemisphere (Figure3).
ThecorrelationbetweenneocorticalPiBandPPCPiBSUVRwas
0.94 (after correction). However, correlations between re-
gionalPPCPiBSUVRandCTEwerenot significant (not shown).
No correlations were found in the NC− group (not shown).
There were no significant correlations between cortical
thickness and episodic memory scores in the NC− group (not
shown). Correlationsweremoderate (r > 0.4) in theNC+group
in the right temporal lobe and right PPCandbut lower (r ≈ 0.2)
andnot significant in the left hemisphere (eFigure 3). The cor-
relationwas significant in the PPC (P < .01) and in the tempo-
ral lobe (P < .02).Thehippocampihad lowcorrelationwithepi-
sodic memory in both NC groups (P = .22 and P = .10, for the
right and left hippocampus, respectively).
In the NC+ group, the correlation between CTE and neo-
cortical PiB SUVR was significant in each anatomical ROI of
Table 3, as well as the correlation between cortical thickness
and episodicmemory except in thehippocampus.When con-
trolling for neocortical PiB retention, the correlation between
cortical thickness andepisodicmemorywas lowerbut still sig-
nificant in the PPC and temporal lobe. When controlling for
cortical thickness, the correlationbetweenneocortical PiB re-
tention and episodic memory was lower and not significant
(P = .15). Cortical thickness in thehippocampuswasnot asso-
ciated with episodic memory.
Longitudinal Analysis of the CTE
Theglobal rate of atrophyover 36months for theNC− andNC+
groups is shown in Figure 4. While the NC− group exhibited
some cortical thickness loss, the loss was greater in the NC+
group, especially in the temporal, PPC, insula, temporo-
occipital, andhippocampal regions. In theNC− group, theGM
loss ranged between 0.0 and 0.015 mm/y in most brain re-
gionswith the exception of the insula, hippocampi, and right
PPC,where theGM loss rangedbetween0.015 and0.04mm/y.
In the NC+ group, the rate of atrophy was larger in the hippo-
campus, parahippocampus, temporal lobes, insula, and right
PPC.No significant cortical thickness losswasobserved in the
frontal areas in any of the groups.
Figure 5 shows the significantly different anatomical ROI
t test on the rate of GM atrophy between the NC− and NC+
groups. The rate of atrophy in the NC+ group was signifi-
cantly faster in both the temporal lobe and hippocampi.
Figure 2. Cortical Thickness Estimation of the Healthy Control Pittsburgh
Compound B–Negative (NC−) and Healthy Control Pittsburgh Compound
B–Positive (NC+) Groups
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P value is less than .05 (false discovery rate corrected). Groups were evaluated
in the 3 different anatomical regions of interest. P value maps are of the t test
between groups. Compared with the NC− group, significantly greater atrophy
was observed in the hippocampus and precuneus and posterior cingulate gyrus
of the NC+ group. INF indicates inferior; LAT, lateral; LT, left; MED, medial;
RT, right; and SUP, superior.
Figure 3. Correlation Between Cortical Thickness and Neocortical
Pittsburgh Compound B in the Healthy Control Pittsburgh Compound
B–Positive Group
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Data are reported in P value maps. P value is less than .05 (false discovery rate
corrected). Gray matter atrophy was significantly associated with neocortical
standardized uptake value ratio in the healthy control Pittsburgh compound
B–positive group bilaterally in the precuneus and posterior cingulate gyrus and
in the right temporal lobe and hippocampus. INF indicates inferior; LAT, lateral;
LT, left; MED, medial; RT, right; and SUP, superior.
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Significantdifferences in the rate of cortical thickness loss
after avertex-wise t test between theNC+andNC−groupswere
observed at both the 18-month (Figure 6A) and 36-month
(Figure 6B) follow-up. While significant atrophy in the NC+
group was restricted to a small area of the right occipital and
temporal lobes at the 18-month follow-up (about 17% of the
right temporal lobe) (Figure 6A), therewasmore extensive at-
rophy in the sameareas at the 36-month follow-up (about 77%
of the right temporal lobe) (Figure 6B) showing a steady pro-
gression of cortical thickness loss. At the 36-month follow-
up, significantly fasterGMatrophywas also found in thePPC,
hippocampus, and some areas of the frontal lobe (Figure 6B).
The rate of GM loss in the NC− group was the same when
evaluated at 36 months and 18 months, while the NC+ group
showeda faster rate of atrophy at 36months. eFigure 4 shows
the average annual rate of atrophy in the right temporal lobe
forNCs. The rate of atrophywas significantly faster in theNC+
group than the NC− group in the right temporal lobe at 36
months.
Discussion
There was a significant difference in cortical thickness be-
tween the NC+ and the NC− groups. The NC+ group exhibited
significantly lowerCTE in thehippocampusandthePPC.These
findings are in agreement with a previous report showing an
associationbetweenPiB retentionandcortical thickness in the
PPCofNCs.27This region isalsopartof thedefaultnetwork,39,40
which has been implicated in memory-related functions al-
tered in AD.41
In contrast, no significant association was found be-
tween PiB retention and cortical thickness when considering
thewholeNCgroup.27 This discrepancy is probablydue to the
large cortical thickness variability in the NC− group, probably
attributable to the heterogeneity of non–AD-related patho-
logical processes in this group where there was no correla-
tion between cortical thickness and PiB retention. However,
a significant correlation was found in the NC+ group bilater-
Table 3. Correlations and Partial Correlations Between CTE, PiB SUVR, and EM in the Right Hemisphere of the NC+ Group
AROI From the Right Hemisphere r(CTE,PiB) r(CTE,EM) r(CTE,EM)/PiB r(PiB,EM) r(PiB,EM)/CTE
PPC −0.43a 0.43a 0.38a −0.19 −0.014
TL −0.53a 0.41a 0.36a −0.19 0.03
Hippocampus −0.68a 0.07 −0.09 −0.19 −0.20
PPC + TL −0.56a −0.48a 0.45a −0.19 0.10
Abbreviations: AROI, anatomical region of interest; CTE, cortical thickness
estimation; EM, episodic memory; NC+, healthy control Pittsburgh compound
B–positive; PiB, Pittsburgh compound B; PPC, precuneus and posterior
cingulate gyrus; r(a,b)/c, partial correlation between a and b while controlling
for c; SUVR, standardized uptake value ratio; TL, temporal lobe.
a Significant correlation.
Figure 4. GrayMatter Atrophy in the Healthy Control Pittsburgh Compound B–Negative (NC−) and Healthy Control Pittsburgh Compound B–Positive
(NC+) Groups
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Rates are reported in millimeters per year. Gray matter loss over 36months was
more extensive, especially in the temporal, precuneus and posterior cingulate
gyrus, and occipital cortices, in the NC+ group compared with the NC− group.
Faster rates of gray matter loss were observed in the hippocampal regions.
INF indicates inferior; LAT, lateral; LT, left; MED, medial; RT, right; and
SUP, superior.
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ally in the PPC and in the temporal lobe and hippocampus of
the right hemisphere. These regions are known to be associ-
ated with early Aβ deposition.15,16 This finding suggests that
Aβ deposition has a direct effect on GM very early in the dis-
ease process, even before overt symptoms are manifested. A
previous study10 had already showed a direct association be-
tween global PiB retention and GM atrophy in AD; however,
our results show that this atrophy, especially in the PPC, oc-
curs at the presymptomatic stages of the disease.
In the NC+ group, while PiB retention was not signifi-
cantly asymmetric, the cortex of the left hemisphere ap-
peared consistently less affected than the right hemisphere.
This is in agreement with a previous study reporting a right-
wardasymmetry incortical thickness inNCs inthe inferior tem-
poral lobe and the medial posterior regions.42
The longitudinal analysis confirmed the regional cross-
sectional findings, further complementing them by showing
a faster GMatrophy in theNC+ group. The rate of atrophywas
particularly fast in the insula in both hemispheres and in the
hippocampus and PPC of the right hemisphere. Both the hip-
pocampus and PPC exhibited significantly faster GM atrophy
in theNC+ group than in theNC− group, thinning thatwas sig-
nificantly associated with PiB retention. As reported previ-
ously, this significant difference suggests an early effect of Aβ
deposition on cortical thickness.27 Furthermore, these find-
ings also validate the results on our previous report based on
a shorter follow-up on some of the same NCs.28
Gray matter atrophy was already present in several
regions of the brain of the NC− group, with rates of GM loss
around 0.02 mm/y, whereas no significant correlation
between cortical thickness and neocortical PiB retention
was found. The mesial temporal cortex was slightly affected
by GM loss in the NC− group and the rate of GM loss was
constant over the 36-month period. This is in agreement
with previous reports on the rates of atrophy associated
with aging,43 suggesting that the GM atrophy in the NC−
group was not driven by AD pathology.
In theNC+ group, the small significant patterns ofGM loss
in the temporal lobe extended fromabout 17%of the total sur-
faceof the lobeat 18months to about 77%at 36months,where
longitudinal analysis ofPiB retentionalso showed thatAβdep-
osition is highest.33
Figure 5. Significant Differences in the Global Rate of GrayMatter
Atrophy Between the Healthy Control Pittsburgh Compound B–Negative
(NC−) and Healthy Control Pittsburgh
Compound B–Positive (NC+) Groups
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Data are reported in P value maps. The rates of atrophy in the NC+ group over
36months were significantly faster than in the NC− group in both temporal
lobes and the hippocampi. INF indicates inferior; LAT, lateral; LT, left;
MED, medial; RT, right; and SUP, superior.
Figure 6. Significant Cortical Thickness Loss in the Healthy Control Pittsburgh Compound B–Positive Group
at the 18-Month and 36-Month Follow-ups
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Panel A indicates 18-month and panel B indicates 36-month follow-ups. Data
are reported in P value maps. In the healthy control Pittsburgh compound
B–positive group, there was a steady progression of cortical thickness loss.
INF indicates inferior; LAT, lateral; LT, left; MED, medial; RT, right; and
SUP, superior.
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In the NC+ group, cortical thickness was also signifi-
cantly associated with episodic memory scores in the tem-
poral lobe and PPC of the right hemisphere. These results
suggest that while the NC+ group is still performing within
the normal range for these tests, there is a direct association
between cortical thickness and memory performance, even
at the presymptomatic stage of the disease. These results
are consistent with previous reports showing that atrophy
in the mesial temporal cortex is associated with the appear-
ance of objective cognitive impairment.44,45 A previous
study already showed an association between local PiB
retention in the temporal lobe and memory impairment.46
The different correlation and partial correlations between
PiB deposition, cortical thickness, and memory decline
showed some evidence of a sequential relationship, where
Aβ deposition locally leads to GM atrophy, which itself
results in memory decline, similar to a previous report in
subjects without dementia.38 While longitudinal assess-
ments of episodic memory performance are needed to con-
firm these findings, they support the push for early thera-
peut ic intervent ion with ant i -Aβ therapy in NC+
individuals47 to reduce the risk of memory decline.
In summary, the present study using a different method-
ological approach to measure GM atrophy confirms and fur-
ther validates in a larger cohort and longer longitudinal evalu-
ation our previous reports showing the relation between Aβ
deposition, GMatrophy, and cognition.9,10,28We have demon-
strated that high Aβ deposition is associated with fast GM at-
rophy in the PPC and hippocampus in cognitively unimpaired
individuals, atrophy that occurs very early in the disease pro-
cess. Moreover, rates of atrophy were faster in the NC+ group,
and with disease progression, atrophy became more exten-
sive, especially in the temporal lobes. Furthermore, GM atro-
phy in NCs+ is associated with episodic memory impairment.
These results support the notion that that Aβ deposition is not
abenignprocessand that cognitivelyunimpairedsubjectswith
substantial Aβ deposition in the brain likely represent a group
at a significantly higher risk of developing dementia.3
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